Urinary catheter | Total | ||
---|---|---|---|
Risk factor | Present (309) n (%) | Absent (174) n (%) | n (%) |
Antibiotic use in preceding 3 month | 220 (71.2) | 118 (67.8) | 338 (70.4) |
UTI in the preceding year | 127 (41.1) | 80 (46.0) | 207 (43.3) |
Infection outside the urinary tract | 131 (42.4) | 35 (20.1) | 166 (34.4) |
Diabetes mellitus | 80 (25.9) | 51 (29.3) | 131 (27.1) |
Chronic renal failure | 65 (21.0) | 37 (21.3) | 102 (21.2) |
Immunosuppressive therapy in preceding 6 month | 43 (13.9) | 46 (26.4) | 89 (18.4) |
Urinary tract operation in preceding 6 month | 55 (17.8) | 33 (19.0) | 88 (18.3) |
Prostate hypertrophy | 49 (15.9) | 32 (18.4) | 81 (18.6) |
Current corticosteroid use | 41 (13.3) | 35 (20.1) | 76 (15.8) |
Urinary tract anomaly | 39 (12.6) | 19 (10.9) | 58 (12.0) |
Urethral stent | 17 (5.5) | 6 (3.4) | 23 (4.8) |
Urinary reflux | 9 (2.9) | 8 (4.6) | 17 (3.5) |
Renal transplantation | 3 (1.0) | 14 (8.0) | 17 (3.5) |
Uterine prolapsus | 3 (1.0) | 8 (4.6) | 11 (4.4) |